Latest Breaking News On - Neha myneni - Page 1 : comparemela.com

Laurus Labs further invests in gene therapy tech, increases its stake in lmmunoACT to 33.86%

ImmunoACT has portfolio of Chimeric Antigen Receptor T cells (CAR-T cells) therapy assets under various development stages for the treatment of multiple auto immune diseases and oncology indications.

India's 1st homegrown mRNA Covid vax may have low market penetration: Report

The recently approved Pune-based Gennova Biopharmaceuticals' two-dose mRNA Covid-19 vaccine, expected to be soon available in the country, is likely to see low penetration in the Indian market, according to a report on Monday.The jab .

India's 1st homegrown mRNA Covid vax may have low market penetration: Report

SII's HPV vaccine to improve affordability for those most in need: GlobalData

The affordable vaccine will significantly improve the overall penetration and help address the growing number of cervical cancer